API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
API
BP/USP/EP
C₄H₁₈NNaO₁₀P₂ · 3H₂O
sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl) phosphonate
121268-17-5
325.1237 g/mol
Bisphosphonates
Musculo-Skeletal
| Appearance | White, crystalline powder |
|---|---|
| Solubility | Water, ethanol |
| Melting point | 196°C |
| pH | 4.46 |
Alendronic acid is indicated for the treatment and prevention of osteoporosis in men and postmenopausal women, treatment of glucocorticoid-induced osteoporosis, and Paget's disease of bone. However, alendronic acid is not indicated for use in pediatric populations.
Alendronic acid binds to bone hydroxyapatite. Bone resorption causes local acidification, releasing alendronic acid which is that taken into osteoclasts by fluid-phase endocytosis. Endocytic vesicles are acidified, releasing alendronic acid to the cytosol of osteoclasts where they induce apoptosis1. Inhibition of osteoclasts results in decreased bone resorption which is shown through decreased urinary calcium, deoxypyridinoline and cross-linked N-telopeptidases of type I collagen.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO-GMP, ISO 9001:2015, FDA-audited facilities |
| Affordability & Generic Access | Cost-competitive generics for global supply |
| Export Experience | Proven track record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
Alendronate Sodium is widely used in Asian countries to treat and prevent osteoporosis, especially in postmenopausal women. It is also used for treating Paget’s bone disease =and steroid-induced osteoporosis. Doctors in Asia prescribe it to improve bone strength and reduce fracture risk.
Yes, Alendronate Sodium can cause dizziness or drowsiness in some users. If you're taking this medicine, avoid driving or operating heavy machinery until you know how it affects your alertness and coordination.
Salius Pharma supplies Alendronate Sodium in bulk as an API (Active Pharmaceutical Ingredient). On request, we also provide finished dosage forms like Alendronate Sodium tablets and chewable tablets, tailored for different market requirements.
To order Alendronate Sodium API, contact Salius Pharma with your specific requirements, including quantity, destination country, and documentation needs such as WHO-GMP, Certificate of Analysis, or Drug Master File (DMF). Our team will guide you through the process.
Salius Pharma exports Alendronate Sodium to several countries, including major Asian markets like Vietnam, Bangladesh, Sri Lanka, and the Philippines. We also supply to African countries such as Nigeria, Kenya, Ghana, and South Africa.
Looking to source Alendronate Sodium Trihydrate or other high-quality pharmaceutical products? We’re here to help. Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support, our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.